Status:
ACTIVE_NOT_RECRUITING
Deprescribing dRrugs for Overactive Bladder in General Practice (DROP)
Lead Sponsor:
Anne Estrup Olesen
Collaborating Sponsors:
University College of Northern Denmark
Conditions:
Overactive Bladder
Deprescribing
Eligibility:
All Genders
65-95 years
Phase:
NA
Brief Summary
The objective is to understand and evaluate the effectiveness of a deprescribing intervention in primary care, specifically targeting medications for overactive bladder in individuals aged 65 or older...
Detailed Description
Potentially inappropriate medication is prescribed medications with an unfavorable risk-benefit profile, for which there might be better, safer, or more cost-effective alternatives. Anticholinergic dr...
Eligibility Criteria
Inclusion
- patient must have been prescribed one of the following drugs for OAB within the last 14 months
- patient must be able to speak and understand Danish
Exclusion
- too cognitively impaired to participate or otherwise unfit to participate as estimated by general practitioner
- receiving neurological or urogenital ambulatory care for their overactive bladder symptoms
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06110975
Start Date
December 1 2023
End Date
December 1 2026
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital
Aalborg, Aalborg, Denmark, 9000